EG20597A - Process for preparing of crystalline n-acetyl neuraminic acid deiwatives - Google Patents

Process for preparing of crystalline n-acetyl neuraminic acid deiwatives

Info

Publication number
EG20597A
EG20597A EG79094A EG79094A EG20597A EG 20597 A EG20597 A EG 20597A EG 79094 A EG79094 A EG 79094A EG 79094 A EG79094 A EG 79094A EG 20597 A EG20597 A EG 20597A
Authority
EG
Egypt
Prior art keywords
deiwatives
crystalline
preparing
neuraminic acid
acetyl neuraminic
Prior art date
Application number
EG79094A
Other languages
English (en)
Inventor
Christopher Williamson
Original Assignee
Bioto Sceint Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioto Sceint Management filed Critical Bioto Sceint Management
Application granted granted Critical
Publication of EG20597A publication Critical patent/EG20597A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EG79094A 1993-12-17 1994-12-15 Process for preparing of crystalline n-acetyl neuraminic acid deiwatives EG20597A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939325841A GB9325841D0 (en) 1993-12-17 1993-12-17 Chemical compounds

Publications (1)

Publication Number Publication Date
EG20597A true EG20597A (en) 1999-09-30

Family

ID=10746778

Family Applications (1)

Application Number Title Priority Date Filing Date
EG79094A EG20597A (en) 1993-12-17 1994-12-15 Process for preparing of crystalline n-acetyl neuraminic acid deiwatives

Country Status (44)

Country Link
US (2) US6294572B1 (no)
EP (1) EP0734382B1 (no)
JP (1) JP3317972B2 (no)
KR (1) KR100403256B1 (no)
CN (2) CN1502621A (no)
AP (2) AP9600810A0 (no)
AT (1) ATE199255T1 (no)
BG (1) BG63338B1 (no)
BR (2) BR9408340A (no)
CA (1) CA2177990C (no)
CO (1) CO4340619A1 (no)
CZ (1) CZ289234B6 (no)
DE (1) DE69426726T2 (no)
DK (1) DK0734382T3 (no)
EE (1) EE03353B1 (no)
EG (1) EG20597A (no)
ES (1) ES2155517T3 (no)
FI (1) FI120453B (no)
GB (1) GB9325841D0 (no)
GR (1) GR3035681T3 (no)
HK (1) HK1014187A1 (no)
HR (1) HRP941001B1 (no)
HU (1) HU221971B1 (no)
IL (1) IL112011A (no)
IS (1) IS4240A (no)
MA (1) MA23396A1 (no)
MY (1) MY116221A (no)
NO (1) NO314759B1 (no)
NZ (1) NZ277789A (no)
OA (2) OA10325A (no)
PE (1) PE31095A1 (no)
PL (1) PL186384B1 (no)
PT (1) PT734382E (no)
RO (1) RO114792B1 (no)
RU (1) RU2134690C1 (no)
SA (1) SA94150417B1 (no)
SG (1) SG46669A1 (no)
SI (1) SI0734382T1 (no)
SK (1) SK282972B6 (no)
SV (1) SV1994000076A (no)
TW (1) TW452577B (no)
UA (1) UA46723C2 (no)
WO (1) WO1995016680A1 (no)
ZA (1) ZA9410003B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
DE759917T1 (de) * 1995-02-27 1998-10-22 Gilead Sciences Inc Neue selektive inhibitoren viraler oder bakterieller neuraminidasen
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
ES2167682T3 (es) * 1996-07-22 2002-05-16 Sankyo Co Derivados del acido neuraminico, su preparacion y su uso medico.
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
TWI291462B (en) 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
WO2013089168A1 (ja) * 2011-12-16 2013-06-20 第一三共株式会社 ノイラミン酸誘導体の製造方法
CN109232677B (zh) * 2018-10-18 2021-12-28 中国科学院合肥物质科学研究院 一种使n-乙酰神经氨酸水合物转化为n-乙酰神经氨酸的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
US5639786A (en) 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CN1142820A (zh) 1997-02-12
RO114792B1 (ro) 1999-07-30
EP0734382B1 (en) 2001-02-21
BR9408340A (pt) 1997-08-19
AU689185B2 (en) 1998-03-26
US6294572B1 (en) 2001-09-25
OA11275A (en) 2002-11-20
CZ169396A3 (en) 1996-11-13
ZA9410003B (en) 1995-07-25
CA2177990C (en) 2000-04-25
AP9600810A0 (en) 1996-07-31
ES2155517T3 (es) 2001-05-16
JP3317972B2 (ja) 2002-08-26
SG46669A1 (en) 1998-02-20
DE69426726T2 (de) 2001-06-21
IS4240A (is) 1995-06-18
SV1994000076A (es) 1995-10-26
DE69426726D1 (de) 2001-03-29
SK282972B6 (sk) 2003-01-09
BR1100548KB1 (pt) 2011-11-01
OA10325A (en) 1997-10-07
PL315055A1 (en) 1996-09-30
FI962464A0 (fi) 1996-06-13
GR3035681T3 (en) 2001-06-29
US20020037865A1 (en) 2002-03-28
UA46723C2 (uk) 2002-06-17
EE03353B1 (et) 2001-02-15
NO962545D0 (no) 1996-06-14
PL186384B1 (pl) 2004-01-30
RU2134690C1 (ru) 1999-08-20
PE31095A1 (es) 1995-10-18
BG63338B1 (bg) 2001-10-31
HUT74938A (en) 1997-03-28
CZ289234B6 (cs) 2001-12-12
HK1014187A1 (en) 1999-09-24
NO962545L (no) 1996-06-14
CN1132829C (zh) 2003-12-31
HRP941001A2 (en) 1997-06-30
AU1314495A (en) 1995-07-03
MA23396A1 (fr) 1995-07-01
HU221971B1 (hu) 2003-03-28
TW452577B (en) 2001-09-01
PT734382E (pt) 2001-06-29
NO314759B1 (no) 2003-05-19
CO4340619A1 (es) 1996-07-30
SI0734382T1 (en) 2001-08-31
JPH09506601A (ja) 1997-06-30
IL112011A0 (en) 1995-03-15
MY116221A (en) 2003-12-31
SK78596A3 (en) 1997-03-05
CN1502621A (zh) 2004-06-09
GB9325841D0 (en) 1994-02-23
NZ277789A (en) 1999-04-29
IL112011A (en) 1998-08-16
DK0734382T3 (da) 2001-03-19
EP0734382A1 (en) 1996-10-02
KR100403256B1 (ko) 2004-04-30
SA94150417B1 (ar) 2005-12-18
HU9601642D0 (en) 1996-08-28
FI120453B (fi) 2009-10-30
CA2177990A1 (en) 1995-06-22
AP9400705A0 (en) 1995-01-31
WO1995016680A1 (en) 1995-06-22
AP541A (en) 1996-10-01
BG100709A (bg) 1997-01-31
FI962464A (fi) 1996-06-13
ATE199255T1 (de) 2001-03-15
HRP941001B1 (en) 2001-06-30

Similar Documents

Publication Publication Date Title
LTIP1431A (en) Process for preparing crystalline sucralose
EG20597A (en) Process for preparing of crystalline n-acetyl neuraminic acid deiwatives
SG55205A1 (en) Methods for improving zero dislocation yield of single crystals
AU2709788A (en) Method for producing processed milk containing galactooligosaccharide
ZA944559B (en) Process for the preparation of pyruvic acid
YU184588A (en) Process for obtaining crystalline monohydrate form of 1-carbacephalosporine
HUT67641A (en) Process for preparation of difluoromethoxy- and difluoromethylthioarenes
HU9603393D0 (en) Process for producing high purity mono-chloroacetic acid
HUT65850A (en) Microbiological process for preparation of 5-hydroxi-pyrazin-carbonic acid
GB2164326B (en) Process for synthesis of crystalline aluminosilicate
HU9303010D0 (en) Process for preparation of 2-methyl-thiazole-5-carboxylates
HUT67910A (en) Process for preparation of 4-alkane-aryl-benzylethers
EP0546906A3 (en) Novel process for preparing 4-amino-5-hexenoic acid
SI0705256T1 (en) Process for the preparation of n-acetyl neuraminic acid derivatives
IL111183A0 (en) Process for the preparation of 5-fluoroanthranilic acid
GB8821237D0 (en) Novel crystalline(metallo)silicates & process for preparing such(metallo)silicates
HUT67669A (en) Process for preparation of chloro-methyl-pyridin derivatives
LTIP499A (en) Microbiological process for preparing malonyl-7-aminocephalosporanic acid derivatives
IL118729A0 (en) Process for the preparation of 5-fluor-2-nitrobenzoic acid
EP0528375A3 (en) Process for the preparation of 2-amino-3-chlorobenzoic acid
HU9903431D0 (en) Microbiological process for production of 6-hydroxinicotinic acid
IL112610A0 (en) Process for preparing physically stable crystalline gamma-modification of para-aminobenzenesulfanylamide
YU15288A (en) Process for obtaining crystalline cephadroxyl chemihydrate
YU250089A (en) Process for conversion of polymorpheous crystalline shape
IE901068L (en) Process for isolating nucleic acid